NCT00005831
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
- Locations
-
- University of Michigan University Hospital Ann Arbor, Michigan, United States
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,952 public trials
630 recruiting studies
Urologic Neoplasms trial results
NCT00006968
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00004879
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +50 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT01276665
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Dep. of Anesthesiology and Pain Therapy, Bern University Hospital Bern, Switzerland
NCT01114230
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Seattle Cancer Care Alliance Seattle, Washington, United States
Completed
Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer
NCT01458847
- Conditions
- Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
- Locations
-
- Tampere University Hospital, Department of Urology Tampere, Finland
- Turku University Hospital, Department of Surgery, Division of Urology Turku, Finland
NCT00873210
- Conditions
- Adenocarcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Pfizer Investigational Site Banská Bystrica, Slovakia
- Pfizer Investigational Site Bojnice, Slovakia
- Pfizer Investigational Site Bratislava, Slovakia
- Pfizer Investigational Site Bratislava, Slovakia
NCT00513175
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +61 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
Completed
Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer
NCT00328861
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +20 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Completed
S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
NCT00058318
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
Not specified